Correlation Between Oncotelic Therapeutics and Cellectis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncotelic Therapeutics and Cellectis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncotelic Therapeutics and Cellectis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncotelic Therapeutics and Cellectis SA, you can compare the effects of market volatilities on Oncotelic Therapeutics and Cellectis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncotelic Therapeutics with a short position of Cellectis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncotelic Therapeutics and Cellectis.

Diversification Opportunities for Oncotelic Therapeutics and Cellectis

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Oncotelic and Cellectis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Oncotelic Therapeutics and Cellectis SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cellectis SA and Oncotelic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncotelic Therapeutics are associated (or correlated) with Cellectis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cellectis SA has no effect on the direction of Oncotelic Therapeutics i.e., Oncotelic Therapeutics and Cellectis go up and down completely randomly.

Pair Corralation between Oncotelic Therapeutics and Cellectis

If you would invest (100.00) in Oncotelic Therapeutics on December 28, 2024 and sell it today you would earn a total of  100.00  from holding Oncotelic Therapeutics or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Oncotelic Therapeutics  vs.  Cellectis SA

 Performance 
       Timeline  
Oncotelic Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Oncotelic Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound essential indicators, Oncotelic Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Cellectis SA 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cellectis SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Oncotelic Therapeutics and Cellectis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncotelic Therapeutics and Cellectis

The main advantage of trading using opposite Oncotelic Therapeutics and Cellectis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncotelic Therapeutics position performs unexpectedly, Cellectis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellectis will offset losses from the drop in Cellectis' long position.
The idea behind Oncotelic Therapeutics and Cellectis SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories